Testing effectiveness (Phase 2)Ended earlyNCT00455897
What this trial is testing
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellLymphoma, Diffuse
Massachusetts General Hospital 3